Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity (Unaudited)

v3.24.2.u1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Apr. 01, 2023   388,665,531      
Beginning balance at Apr. 01, 2023 $ 2,910,713 $ 97,166 $ 3,775,979 $ (1,019,518) $ 57,086
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (57,425)       (57,425)
Dividends on common stock (116,575)   (59,489)   (57,086)
Stock-based compensation, net (in shares)   171,014      
Stock-based compensation, net 14,061 $ 43 17,287   (3,269)
Foreign currency translation and other (13,149)     (13,149)  
Defined benefit pension plans 6,481     6,481  
Derivative financial instruments $ (27,343)     (27,343)  
Ending balance (in shares) at Jul. 01, 2023 388,836,545 388,836,545      
Ending balance at Jul. 01, 2023 $ 2,716,763 $ 97,209 3,733,777 (1,053,529) (60,694)
Beginning balance (in shares) at Mar. 30, 2024 388,836,219 388,836,219      
Beginning balance at Mar. 30, 2024 $ 1,658,365 $ 97,209 3,600,071 (1,064,331) (974,584)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (258,886)       (258,886)
Dividends on common stock (35,015)   (35,015)    
Stock-based compensation, net (in shares)   345,423      
Stock-based compensation, net 12,737 $ 86 15,119   (2,468)
Foreign currency translation and other (19,453)     (19,453)  
Defined benefit pension plans 3,632     3,632  
Derivative financial instruments $ 26,525     26,525  
Ending balance (in shares) at Jun. 29, 2024 389,181,642 389,181,642      
Ending balance at Jun. 29, 2024 $ 1,387,905 $ 97,295 $ 3,580,175 $ (1,053,627) $ (1,235,938)